Work

Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression

Year: 2014

Type: article

Source: Journal of Affective Disorders

DOI: 10.1016/j.jad.2014.09.015

Authors: Robin Ortiz, Mark J. Niciu, Nada Lukkahati, Leorey N. Saligan, Allison C. Nugent, David A. Luckenbaugh, Rodrigo Machado-Vieira, Carlos A. Zarate

Institutions: National Institutes of Health, National Institute of Mental Health, University of Nevada, Las Vegas, National Institute of Nursing Research

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Howard Hughes Medical Institute, National Institutes of Health, National Institute of Mental Health

Awards: G9000079022, Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders

OpenAlex ID: W2073250374

FWCI: 2.597

Cites: 27

Cited by: 32

Related to: 10